Esketamine hydrochloride Clinical Trials
5 recruitingDrug
Phase 33Phase 42
Showing 1–5 of 5 trials
Recruiting
Phase 3
Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure
Major Depressive DisorderBipolar DepressionSchizophrenia and Related Disorders
Dr. Inge Winter1,254 enrolled1 locationNCT05603104
Recruiting
Phase 3
The Effect of a Six Week Intensified Pharmacological Treatment for Major Depressive Disorder Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
Major Depressive DisorderTreatment Resistant Depression
Dr. Inge Winter418 enrolled12 locationsNCT05973851
Recruiting
Phase 4
Immunoinflammatory Regulation of Esketamine in Septic Patients
SepsisInflammatory ResponseEsketamine+1 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology100 enrolled2 locationsNCT04843982
Recruiting
Phase 3
Esketamine as Treatment for Chronic Pain Due to Endometriosis: a RCT Study
Chronic Pelvic Pain SyndromeEndometriosis
Reinier de Graaf Groep56 enrolled1 locationNCT06161805
Recruiting
Phase 4
Effects of Esketamine on Postoperative Behavioral Changes in Children Undergoing Tonsillectomy and/or Adenoidectomy
Behavior Problem
Fujian Provincial Hospital172 enrolled1 locationNCT06579937